Direct targeting of tumor cell F1F0 ATP-synthase by radioiodine angiostatin in vitro and in vivo

Cancer Biotherapy and Radiopharmaceuticals

Volumn 22, Issue 5, 2007, Pages 704-712

  Jung, Kyung Ho ^a   Song, Sung Hee ^a   Paik, Jin Young ^a   Koh, Bong Ho ^a   Choe, Yearn Seong ^a   Lee, Eun Jung ^a   Kim, Byung Tae ^a   Lee, Kyung Han ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Angiogenesis; Angiostatin; ATP synthase; Radioiodine; Tumor

Indexed keywords

ANGIOSTATIN; ANGIOSTATIN I 123; ENZYME ANTIBODY; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER SCINTISCANNING; CELLULAR DISTRIBUTION; COLON CARCINOMA; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; ENDOTHELIUM CELL; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIODINATION; RAT; SARCOMA CELL; TUMOR XENOGRAFT;

6-AMINOCAPROIC ACID; ANGIOSTATINS; ANIMALS; ANTIBODIES; CELL LINE; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; PROTEIN BINDING; PROTON-TRANSLOCATING ATPASES; RATS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 35848951624     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.369     Document Type: Article

References (20)

1. O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:689.
2. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315.
3. Tarui T, Miles LA, Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem 2001;276:39562.
4. Troyanovsky B, Levchenko T, Mansson G, et al. Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 2001;152:1247.
5. Wahl ML, Kenan DJ, Gonzalez-Gronow M, et al. Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated. J Cell Biochem 2005;96:242.
6. Moser TL, Stack MS, Asplin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci U S A 1999;96:2811.
7. Moser TL, Kenan DJ, Ashley TA, et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci U S A 2001;98:6656.
8. 0 ATP synthase: A new paradigm? Ann of Med 2006;38:429.
9. Champagne E, Martinez LO, Collet X, et al. Ecto-F1Fo ATP synthase/F1 ATPase: Metabolic and immunological functions. Curr Opin Lipidol 2006;17:279.
10. Hajitou A, Grignet C, Devy L, et al. The antitumoral effect of endostatin and angiostatin is associated with a downregulation of vascular endothelial growth factor expression in tumor cells. FASEB J 2002;16:1802.
11. Gonzalez-Gronow M, Grenett HE, Gawdi G, et al. Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor, CD26. Exp Cell Res 2005;303:22.
12. Chi SL, Pizzo SV. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: A mechanism dependent on cell surface-associated ATP synthase. Cancer Res 2006;66:875.
13. Song SH, Jung KH, Paik JY, et al. Distribution and pharmacokinetic analysis of angiostatin radioiodine labeled with high stability. Nucl Med Biol 2005;32:845.
14. Lee KH, Song SH, Paik JY, et al. Specific endothelial binding and tumor uptake of radiolabeled angiostatin. Eur J Nucl Med Mol Imaging 2003;30:1032.
15. +-ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol Cancer Res 2003;1:931.
16. Veitonmaki N, Cao R, Wu LH, et al. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Cancer Res 2004;64:3679.
17. Hammond LA, Denis L, Salman U, et al. Positron emission tomography (PET): Expanding the horizons of oncology drug development. Invest New Drugs 2003;21:309.
18. Martinez LO, Jacquet S, Esteve JP, et al. Ectopic betachain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003;421:75.
19. Kim KB, Lee JW, Lee CS, et al. Oxidation-reduction respiratory chains and ATP synthase complex are localized in detergent-resistant lipid rafts. Proteomics 2006;6:2444.
20. Kenan DJ, Wahl ML. Ectopic localization of mitochondrial ATP synthase: A target for anti-angiogenesis intervention? J Bioenerg Biomembr 2005;37:461.